Keros Therapeutics will use the Massachusetts General Hospital MyMatch program to design a clinical trial testing rinvatercept for ALS.

STELLAR-2, a randomized, double-blind, sham-controlled study, will evaluate the effects of salanersen when initiated ~6 months after onasemnogene abeparvovec-xioi in infants with SMA who received ...

ARV-102 reduced endolysosomal and neuroinflammatory biomarkers implicated in Parkinson’s disease and progressive supranuclear palsy - ...

Multiple sclerosis (MS) is a chronic, often debilitating autoimmune disease that affects the central nervous system (CNS). This disease causes the immune system to mistakenly attack the protective ...

New treatments for neurodegenerative diseases like Alzheimer's, Parkinson's, and motor neuron disease (MND) could be unlocked thanks to microscopic medicines developed by researchers at the University ...

The human brain develops through an intricate balance of cellular growth, connectivity, and metabolism. A new study reveals ...

Researchers identify a conserved brainstem and spinal cord pathway (C3-C4) that controls voluntary hand movements in both mice and humans.

Researchers create the first high-resolution molecular atlas of the fruit fly brain, revealing how lineage and birth order define neuronal identity.

A newly identified role for the neuronal MPS shows it controls nutrient uptake by acting as a gatekeeper. Its disruption ...